Gts Securities LLC Summit Therapeutics Inc. Call Options Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
Call Options
1 transactions
Others Institutions Holding SMMT
# of Institutions
224Shares Held
79.5MCall Options Held
2.16MPut Options Held
3.1M-
Baker Bros. Advisors LP New York, NY24.4MShares$481 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$156 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$107 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$68.3 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.96B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...